Empowering mental health professionals with peer-reviewed psychiatric research and insights

Page 31

More JCP Articles

JCP
Very Low-Level Transcranial Photobiomodulation for MDD
JCP
Cannabidiol for Treatment-Resistant Anxiety
JCP
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
JCP
Tardive Dyskinesia and Long-Acting Injectable Antipsychotics
JCP
A Mirror-Image Trial or Smoke and Mirrors? Phase 3b Study on Digital Aripiprazole
JCP
Psychotropic Drugs With Long Half-Lives: Implications for Drug Discontinuation, Dosing, and Pregnancy Planning
JCP
Association of Distress Due to Systemic Racism and Racial Disparities With Psychopathology and Suicidal Ideation Among Veterans During COVID-19
JCP
Timely Diagnosis of Alzheimer Disease
JCP
Add-on Pramipexole for Schizophrenia
JCP
Treatment of Early-Stage Alzheimer Disease
JCP
Depression Severity, Psychotic Depression, and Suicide Risk
JCP
The Practical Importance of Half-Life in Psychopharmacology